|
|
|
|
|
|
|
|
|
|
|
|
|
07.05.26 - 23:42
|
McKesson Corp. Reveals Increase In Q4 Profit (AFX)
|
|
|
WASHINGTON (dpa-AFX) - McKesson Corp. (MCK) reported earnings for its fourth quarter that Increases, from the same period last yearThe company's bottom line totaled $1.68 billion, or $13.78 per sh......
|
|
|
|
|
07.05.26 - 22:15
|
McKesson Reports Fiscal 2026 Fourth Quarter and Full Year Results, Provides Fiscal 2027 Guidance, and Reaffirms Long-Term Financial Growth Targets (Business Wire)
|
|
|
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2026 fourth quarter financial results. Results can be accessed on McKesson's Investor Relations website at investor.mckesson.com/financials/quarterly-results.
As previously announced, the company will host a live webcast of the earnings conference call for investors today, Thursday, May 7, at 4:30 PM ET to review its financial results. The audio webcast of the conference call will be available live and archived on McKesson's Investor Relations website, along with the company's earnings press release, financial tables, and slide presentation. Additional information about upcoming events for the investor community can be found at investor.mckesson.com/events-and-presentations.
About McKesson Corporation
McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, g...
|
|
|
|
|
|
|
|
|
28.04.26 - 18:02
|
William Blair Initiates Cardinal Health at Outperform: Is the Pharma Distributor a Stealth Compounder? (24/7 Wall St.)
|
|
|
William Blair launched coverage of Cardinal Health (NYSE:CAH) with an Outperform rating today, framing the pharma distributor as a durable franchise with specialty-led upside. The firm simultaneously initiated McKesson (NYSE:MCK) at Outperform, a dual launch that signals conviction in the U.S. drug-distribution oligopoly. For prudent investors, the call tightens an already constructive sell-side picture on ... William Blair Initiates Cardinal Health at Outperform: Is the Pharma Distributor a Stealth Compounder?...
|
|
|
|
|
22.04.26 - 14:06
|
McKesson Corporation Declares Quarterly Dividend (Business Wire)
|
|
|
IRVING, Texas--(BUSINESS WIRE)--The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 82 cents per share of common stock. The dividend will be payable on July 1, 2026, to shareholders of record on June 1, 2026.
About McKesson Corporation
McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson is impacting virtually every aspect of healthcare at McKesson.com and read Stories & Insights.
We routinely use our website, investor.mckesson.com, to post information that may be material to investors, such as business developments, earnings, and financial performance, as well as presentation materials and details for upcoming and past events. Contacts
Investors...
|
|
|
|
|
21.04.26 - 14:06
|
CryoFuture Appoints Michael Fiore to Board to Support Cryostorage and Transport Expansion (Business Wire)
|
|
|
LOS ANGELES--(BUSINESS WIRE)--CryoFuture, a leader in advanced cryostorage, transportation, and reproductive tissue management solutions, today announced the appointment of Michael Fiore to its Board of Directors. A highly accomplished healthcare executive with more than four decades of experience building and scaling complex healthcare organizations, Mr. Fiore will support CryoFuture's continued expansion as demand for long-term fertility specimen storage and transport continues to grow.
Mr. Fiore brings a distinguished track record in healthcare services, having co-founded Vantage Oncology in 2002, where he served as Chairman and Chief Executive Officer until its acquisition by McKesson in 2016. Under his leadership, Vantage Oncology grew into a nationally recognized provider of integrated oncology services, establishing a strong foundation for scalable, patient-centered care delivery.
Mr. Fiore also brings direct cryostorage experience, having previously served as Chairman of California Cryobank prior...
|
|
|
|
|
|
|
|
|
20.04.26 - 14:06
|
McKesson Signs Agreement with Apollo Funds for Strategic Minority Interest in Medical-Surgical Solutions (Business Wire)
|
|
|
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK), a leading Healthcare Services company, today announced it has entered into a definitive agreement with funds managed by affiliates of Apollo (“Apollo Funds”), under which Apollo Funds will acquire a minority ownership interest in McKesson's Medical-Surgical Solutions (“MMS”) business. This transaction represents a meaningful milestone as McKesson executes its separation strategy of MMS in preparation of a planned initial public offering.
Apollo Funds will invest $1.25 billion in convertible preferred equity of MMS to acquire an approximately 13% minority interest in MMS. The transaction values MMS at approximately $13 billion total enterprise valuation. McKesson will retain operating control and majority ownership of MMS and consolidate the results for financial reporting. The transaction is subject to regulatory approvals and customary closing conditions.
“This transaction marks a key milestone in McKesson's planned separation ...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
